Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

Clinical trial NCT03836066 · COMPLETED

Trial details

NCT number: NCT03836066
Sponsor: Fundación GECP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2019-05-15
Primary completion: 2024-10-21
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.